SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Corteva, Inc. is a global pure-play agriculture company that combines innovative technologies, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. It generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. The company leverages recognized agricultural brands and a robust technology pipeline to maximize productivity for farmers while working with stakeholders throughout the food system to fulfill its promise of enriching the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva was founded in 1802 and is headquartered in Indianapolis, IN.

Corteva Inc

Cortevas seed and genetics spin-off into Vylor has sharply reset CTVAs quoted share price, with shareholders receiving one Vylor share per Corteva share; traders debate whether the post-separation selloff goes beyond the mechanical adjustment. Some see a valuation opportunity and expect a rebound, while others argue the lower price reflects Cortevas smaller standalone crop-protection business.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns record quarterly results and stronger outlook, alongside managements warning that AI-driven memory supply will remain tight through 202728, are driving attention. Traders are frustrated that the stock has barely responded or fallen despite the strong report, debating whether growth was already priced in and pointing to margin and spending concerns, while bulls see the extended shortage as evidence of durable demand.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture shares surged after quarterly revenue and earnings beat expectations and annual bookings reached a record, easing concerns about consulting demand. Bulls view the bookings as evidence that AI-related work is translating into client demand, while skeptics argue the rally may be excessive given modest growth guidance and lingering fears that AI could disrupt traditional consulting.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia is under pressure after a Delaware court found that Yutrepia infringes two United Therapeutics patent claims covering its PH-ILD use; the final remedy remains uncertain, with Liquidia planning an appeal and seeking to remove that indication from the label. Traders debate the risk of broader sales restrictions against the possibility that the selloff is excessive, with some buying the dip while others see the stock as highly risky.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths business-combination approval and planned Nasdaq listing as an XRP treasury company are driving attention, with traders reacting to the deals progress and expected XRP holdings. The discussion is broadly bullish on the XRP-linked exposure and warrants, but also centers on redemption levels, the post-merger float and warrant mechanics, alongside concerns about SPAC volatility and pullbacks.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingos rebound is drawing attention after an analyst upgrade tied to product improvements and stronger user-growth trends. Bulls see AI as enhancing the platform and point to potential short covering, while skeptics remain concerned about AI competition, valuation, and whether user growth will translate into revenue.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenus is drawing attention around updated NEST Phase 2 results for its BOT+BAL immunotherapy combination in resectable colorectal cancer and the shift toward the ROBBIN Phase 3 program. Bulls see the data and recent financing as signs of progress, while skeptics point to the small, non-randomized study, delays to Phase 3, and dilution and management concerns.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicors latest increase to its Q3 sequential revenue-growth outlook, attributed to higher royalties from a non-exclusive Vertical Power Delivery license to an AI OEM, is driving attention. Traders are broadly celebrating the guidance and AI power-delivery opportunity, while some caution that the rally may have priced in much of the upside and are taking profits.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is drawing attention amid a rotation into enterprise software as investors weigh AI-related concerns and chip-sector volatility; traders view its workflow and AI-governance products as a way to benefit from enterprise AI adoption rather than be displaced by it. Optimism is reinforced by analyst upgrades, though some traders remain cautious about valuation, interest rates, and the software sectors choppy price action.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa, with FDA review acceptance and timing still pending, is the main focus alongside anticipated adolescent data. Traders are split: some view the regulatory milestone as a potential catalyst, while others point to dilution, IZAR results that fell short of expectations, and concerns about managements go-it-alone strategy as reasons for the share-price decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PRCT PROCEPT’s second-quarter revenue rose 19% to $94.5 million, but its net loss widened to $26.9 million. Here’s the tension behind this focused medical robotics stock. https://biotechhealthx.com/biotech-news/procept-prct-has-a-robot-a-growth-story-and-a-26-9m-problem/

Achin

AStateofTrance7

PROCEPT's second-quarter revenue rose 19% to $94.5 million, but its net loss widened to $26.9 million. Here's the tension behind this focused medical robotics stock.

BioTech Health X

PROCEPT (PRCT) Has a Robot, a Growth Story, and a $26.9M Problem

StockTwits Web

Procept BioRobotics Corp

 PROCEPT’s second-quarter revenue rose 19% to $94.5 million, but its net loss widened to $26.9 million. Here’s the tension behind this focused medical robotics stock. 